Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “gMG”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Testing effectiveness (Phase 2)Ended earlyNCT00727194
What this trial is testing

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 14
Not applicableLooking for participantsNCT06909253
What this trial is testing

Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
AstraZeneca 50
Early research (Phase 1)Not Yet RecruitingNCT06759948
What this trial is testing

An Early Exploratory Clinical Study of GC012F Injection in the Treatment of Refractory Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Chongbo Zhao 18
Large-scale testing (Phase 3)Study completedNCT01997229
What this trial is testing

Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 125
Early research (Phase 1)Not Yet RecruitingNCT07818291
What this trial is testing

An Open-label, Dose-escalation Phase Ib Study of EA5 Injection in Adults With Anti-AChR Antibody-Positive Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis (gMG)
Shanghai Lanyi Therapeutics Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT07673627
What this trial is testing

ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

Who this might be right for
AChR-Ab Seropositive Generalized Myasthenia GravisMyasthenia Gravis (MG)MG - Myasthenia Gravis+1 more
argenx 40
Not applicableNot Yet RecruitingNCT07226830
What this trial is testing

Quantification of Change in MG Disease Activity in Individuals With Generalized Myasthenia Gravis (gMG) After Administration of VYVGART® or VYVGART Hytrulo® Using BioDigit MG

Who this might be right for
Myasthenia Gravis Generalized
BioSensics 25
Large-scale testing (Phase 3)Enrolling By InvitationNCT06435312
What this trial is testing

An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 8
Large-scale testing (Phase 3)Enrolling By InvitationNCT06540144
What this trial is testing

An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 12
Post-approval studies (Phase 4)Looking for participantsNCT07221838
What this trial is testing

Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

Who this might be right for
Generalized Myasthenia GravisgMG
Alexion Pharmaceuticals, Inc. 75
Large-scale testing (Phase 3)UnknownNCT05716035
What this trial is testing

Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis, Generalized
Tang-Du Hospital 64
Large-scale testing (Phase 3)Looking for participantsNCT06744920
What this trial is testing

Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
Novartis Pharmaceuticals 180
Large-scale testing (Phase 3)Study completedNCT02301624
What this trial is testing

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

Who this might be right for
Refractory Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc. 117
Not applicableLooking for participantsNCT07247279
What this trial is testing

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in Russia

Who this might be right for
Rare DiseasesGeneralized Myasthenia Gravis (gMG)
AstraZeneca 450
Large-scale testing (Phase 3)Active Not RecruitingNCT06149559
What this trial is testing

Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 14
Not applicableLooking for participantsNCT07294170
What this trial is testing

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

Who this might be right for
Myasthenia GravisMGgMG+3 more
argenx 70
Large-scale testing (Phase 3)Enrolling By InvitationNCT05374590
What this trial is testing

Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia GravisgMG
argenx 12
Post-approval studies (Phase 4)Looking for participantsNCT07246564
What this trial is testing

Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis

Who this might be right for
Myasthenia Gravis
UCB Biopharma SRL 40
Large-scale testing (Phase 3)Looking for participantsNCT06055959
What this trial is testing

Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

Who this might be right for
Generalized Myasthenia Gravis
UCB Biopharma SRL 8
Large-scale testing (Phase 3)Study completedNCT03759366
What this trial is testing

Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

Who this might be right for
Myasthenia GravisMyasthenia Gravis, Juvenile FormMyasthenia Gravis, Generalized
Alexion Pharmaceuticals, Inc. 12
Next Page